Medical News on Cancer

First Model Of Aggressive Ovarian Cancer Demonstrates Immune System's Active Role In Tumor Progression

Feb 22, 2012

Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer. New findings from scientists at The Wistar Institute demonstrate that ovarian tumors don't necessarily break "free" of the immune system, rather dendritic cells of the immune system seem to actively support the tumor's escape... Read More

Targeted Tumor Freezing Therapy Increases Ovarian Cancer Survival

Feb 20, 2012

Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients. The "freeze and destroy" technique is an alternative for local treatment of cancerous tumors, said Peter Littrup, M.D... Read More

Researchers Identify Cycle Of Platelet Production In Ovarian Cancer Patients

Feb 17, 2012

Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine... Read More

Ovarian Cancer - Best Imaging Technique Revealed

Feb 16, 2012

According to a study published in the journal Radiology, researchers from Cancer Research UK's Cambridge Experimental Cancer Medicine Center at the University of Cambridge, have determined that the best method to monitor how women with late-stage ovarian cancer are responding to treatment may be a magnetic resonance imaging (MRI) technique... Read More

Anti-Angiogenic Drugs May Be Effective Against New Subtype Of Ovarian Cancer

Feb 16, 2012

Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to "anti-angiogenic" drugs that block blood vessel formation... Read More

Differences Between Primary And Recurrent Ovarian Cancers Revealed By Molecular Profiling

Feb 14, 2012

There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine the differences in the molecular characteristics of primary and recurrent ovarian tumors and found significant changes for some biomarkers... Read More